curriculum vitae
MARGARET OTTAVIANO
Department of Clinical Medicine and Surgery
Division of Oncology
University of Naples Federico II
Via S. Pansini, 5
80131, Naples, Italy
Telephone: +39/0817462114
Fax: +39/2203147
E-mail: [email protected]
Personal information
Surname(s) / First name(s)
Address(es)
Telephone(s)
Mobile(s)
Fax(s)
E-mail(s)
Nationality(-ies)
Date of birth
Gender
Work experience
Name and address of employer
Date(from-to)
Occupation or position held
Education
Date
Title of qualification awarded
Name and type of organisation
providing education and training
Vote
Date(from-to)
Title of qualification awarded
Name and type of organisation
providing education and training
1
Margaret Ottaviano
9, via Giuseppe Di Vittorio, 80046, San Giorgio a Cremano, Napoli, Italy
0039 081 19910297
0039 3333759668
0039 081 220 3147
[email protected]
Italian
03/02/1986
Female
Dipartimento di Medicina Clinica e Chirurgia,
Università degli studi di Napoli Federico II, Naples, Italy
August 2013 to present
Medical Oncologist in training
2013
Bachelor Degree in Medicine and Surgery at University of Naples, Federico II (Laurea in
Medicina e Chirurgia)
University of Naples Federico II
110/110 cum laude plus mention to career
2009-2010
Exchange Erasmus Project At Faculty of Medicine,
Instituto de Ciencias Biomedicas Abel Salazar,
Universidade do Porto, Oporto, Portugal
Date(From-to)
Title of qualification awarded
Name and type of organisation
providing education and training
Vote
Research Experiences
Date (from-to)
Title of qualification awarded
Date (from-to)
Title of qualification awarded
2004
High school degree at Liceo Scientifico
Liceo Scientifico Carlo Urbani in San Giorgio a Cremano, Naples, Italy
100/100
2011 to present
Clinical cancer research at CRTR (Centro Riferimento Tumori Rari Regione Campania)
University of Naples Federico II
focused mainly on thymic epithelial tumors, germinal testicular cancer, soft tissue sarcoma and
GIST, neuroendocrine tumors, hepatocellular carcinoma, malignant melanoma and head-neck
carcinoma, for development of predictive markers to treatment response; participation at phase
II and phase III trials as sub-investigator
Research Supervisor: Prof. Giovannella Palmieri,
Director of CRTR, Department of Clinical Medicine and Surgery
University of Naples Federico II
01 May 2016 to 15 June 2016
Spring 2016 ESMO Clnical Unit Visit Felloship winner
Temporary clinical research fellow at Royal Marsden Cancer Foundation, Sutton, UK
Clinical research mainly focused on these topics of genito-urinary cancer and related issues:
adrenal insufficiency in mCRPC treated with steroids; steroids switch from prednisone to
dexamethasone as treatment line in mCRPC; identification of biomarkers predictive of poor
outcome in poor prognosis advanced germ cell cancer.
Research Supervisor: Dr. Alison Reid
Medical Oncologist Consultant at Royal Marsden Cancer Foundation, Department of Urological
Oncology
Membership
Date(from-to)
Title of qualification awarded
Date(from-to)
Title of qualification awarded
Date(from-to)
Title of qualification awarded
Date(from-to)
Title of qualification awarded
2
July 2013
Inscription to Albo Professionale dei Medici Chirurghi di Napoli
September 2013
ENETS medical oncologist member
November 2014
IGG (Italian Germinal Group) young oncologist member
January 2015
ESMO (European Society of Medical Oncology) young oncologist member
Date(from-to)
Title of qualification awarded
Organizational Skills and
Competences
January 2017
ASCO Medical Oncologist member
Management of oncological emergencies
Management of pain therapy
Management of clinical phase I, II, III trials and observational studies
Excellent ability to adapt to multicultural environments, gained through my work and study
experiences
Team spirit enhanced through my work experiences
High level of moral and ethical standards;
Good communication skills gained through my studies
Leadership
Good experience in project and team management
Sense of organization
Good experience in project group
Experience in clinical trial
Clinical investigator in a phase II trials on thymic epithelial tumours, neuroendocrine tumours,
malignant melanoma, soft tissue sarcoma, hepatocellular carcinoma, L-Histiocytosis, Head-neck
cancer, and testicular germinal cancer.
Management of clinical phase II, III and observational studies
Personal skills and competences
Mother tongue(s)
Italian
Other Languages
English
Self-assessment
European level (*)
Other Languages
Self-assessment
European level (*)
Other Languages
Self-assessment
European level (*)
Understanding
Writing
Listening
Reading
Spoken interaction
Spoken production
C2
C2
C1
C1
C1
Portuguese
Understanding
Speaking
Writing
Listening
Reading
Spoken interaction
Spoken production
C2
C2
C2
C2
C2
Spanish
Understanding
Speaking
Writing
Listening
Reading
Spoken interaction
Spoken production
B2
B2
B2
B2
(*) Common
3
Speaking
European Framework of Reference (CEF) level
B2
Social skills and competences
Organisational skills and
competences
Computer skills and competences
Awards
Publications
I have strong analysis and summary skills, strong communicative capabilities, I'm always meticulous
and resolute
I work very well in team
Office automation Applications
ITMIG Shanghai 2015 travel grant winner
Spring 2016 ESMO Clinical Unit Visit Fellowship winner
ITMIG San Francisco 2016 travel grant winner
ESO-ESMO 2017 Oncology masterclass
Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumor
Roberto Moretto, Chiara Alessandra Cella, Lucia Raimondo, Luigi Formisano, Lucia Nappi,
Pasquale Rescigno, Carlo Buonerba, Filomena Calabrese, Margaret Ottaviano, Giuseppe Di
Lorenzo, Elide Matano, Vincenzo Damiano, Giovannella Palmieri
Anticancer Drugs. 2013 Aug;24(7):759-64
Capecitabine plus gemcitabine in thymic epithelial tumors: final analysis of a phase II trial
Giovannella Palmieri, Carlo Buonerba, Margaret Ottaviano, Piera Federico, Filomena Calabrese,
Claudia von Arx, Ana Paula De Maio, Mirella Marino, Maurizio Lalle, Liliana Montella, Carmela
Merola, Michele Milella, Marina Bergaglio, Giuseppe Di Lorenzo, Vincenzo Damiano.
Future Oncology 2014 Nov;10(14):2141-7.
Molecular genetic alterations in EGFR CA-SSR-1 microsatellite and EGFR copy number
changes are associated with aggressiveness in Thymoma
Salvatore Conti, Enzo Gallo, Stefano Sioletic, Francesco Facciolo, Giovannella Palmieri, Libero
Lauriola, Amelia Evoli, Robert Martucci, Anna Di Benedetto, Flavia Novelli, Diana Giannarelli, Gloria
Deriu, Pierluigi Granone, Margaret Ottaviano, Paola Muti, Edoardo Pescarmona, Mirella Marino
J Thorac Dis. 2016 Mar;8(3):386-95.
The future of melanoma therapy: developing new drugs and improving the use of old ones.
Palumbo G, Di Lorenzo G, Ottaviano M, Damiano V.
Future Oncol. 2016 Oct 7. [Epub ahead of print]
Abstracts
Abstract Presented to ITMIG 2016, San Francisco, LA, USA
Proposed paradigm for the second line treatment in thymic epithelial tumours
Margaret Ottaviano, Vincenzo Damiano, Silvana Del Vecchio, Sabrina Segreto, Pasquale
Rescigno, Elide Matano, Mirella Marino, Giovannella Palmieri.
Selected as poster presentation
The evolving role of Sunitinib in the management of highly pre-treated thymic carcinoma
Giovannella Palmieri, Margaret Ottaviano, Pasquale Rescigno, Mirella Marino, Giuliano Palumbo,
Alfredo Di Giovanni, Carmen Forino, Vincenzo Damiano.
Selected as poster presentation
4
The unexplored paradox of autoimmunity and immunodeficiency in thymomas: a
monocentric experience
Margaret Ottaviano, Vincenzo Damiano, Alfredo Di Giovanni, Carmen Forino, Giovannella Palmieri.
Selected as poster presentation
Platinum based chemotherapy in advanced thymic epithelail tumours: always the best
choice?
Vincenzo Damiano, Margaret Ottaviano, Elide Matano, Alfredo Di Giovanni, Sabino De Placido,
Giovannella Palmieri.
Selected as poster presentation
Abstract Presented to ITMIG 2015, Shanghai, China, Asia
18 FDG-PET/CT for early prediction of response to first line platinum chemotherapy in
advanced TETs
Giovannella Palmieri, Margaret Ottaviano, Silvana Del Vecchio, Sabrina Segreto, Irene Tucci,
Vincenzo Damiano
Selected as poster presentation
Effectiveness of cytotoxic agent etoposide after target therapy in advanced thymic tumors
Margaret Ottaviano, Vincenzo Damiano, Claudia von Arx, Irene Tucci, Lucia Nappi, Pasquale
Rescigno, Giuliano Palumbo, Sabino de Placido, Giovannella Palmieri.
Selected as poster presentation
Is the Octreoscan score a predictive factor of response to Somatostatin analogs treatment?
Vincenzo Damiano, Margaret Ottaviano, Silvana Del Vecchio, Sabrina Segreto, Irene Tucci,
Claudia von Arx, Giuliano Palumbo, Sara Pellegrino, Sabino de Placido, Mirella Marino, Giovannella
Palmieri.
Selected as poster presentation
Diagnosis of advanced thymic epithelial tumor in patients previously affected by thymic
hyperplasia
Vincenzo Damiano, Margaret Ottaviano, Irene Tucci, Elide Matano, Sabino de Placido, Giovannella
Palmieri
Selected as poster presentation
Abstract Presented to ASCO 2015, Chicago Illinois, USA
Somatostatin analogs as maintenance therapy in heavily pretreated thymic epithelial tumor
Giovannella Palmieri, Margaret Ottaviano, Lucia Nappi, Pasquale Rescigno, Mirella Marino, Liliana
Montella, Mariateresa Micillo, Giuliano Palumbo, Silvana Del Vecchio, Vincenzo Damiano
Selected as poster presentation
Effectiveness of somatostatin analogs plus prednisone in aggressive histotype and
advanced stage of thymic epithelial tumors
Margaret Ottaviano, Vincenzo Damiano, Lucia Nappi, Pasquale Rescigno, Liliana Montella, Mirella
Marino, Silvana Del Vecchio, Irene Tucci, Claudia von Arx, Giovannella Palmieri
Selected as poster presentation
Abstract presented to AIOM 2015, Rome, Italy, Europe
Correlation between plasmatic levels of vitamin D and testicular cancer
Lucia Nappi, Vincenzo Damiano, Margaret Ottaviano, Pasquale Rescigno, Caterina Condello,
Claudio Curcio, Ciro Candido, Elide Matano, Giovannella Palmieri
Selected as poster presentation
5
Abstract Presented to ITMIG 2014, Antwerp, Belgium, Europe
Effectiveness of dual target Everolimus and Somatostatin Analogs in heavily
Pretreated Thymic Epithelial Tumors.
Giovannella Palmieri, Margaret Ottaviano, Carlo Buonerba, Piera Federico, Filomena Calabrese,
Claudia von Arx, Stefano De Falco, Lucia Nappi, Pasquale Rescigno, Mirella Marino, Vincenzo
Damiano.
Selected as poster presentation
Long lasting management of functional neuroendocrine thymic carcinoma
Margaret Ottaviano, Claudia von Arx, Stefano De Falco, Carlo Buonerba, Piera Federico, Filomena
Calabrese, Lucia Nappi, Pasquale Rescigno, Vincenzo Damiano, Giovannella Palmieri.
Selected as poster presentation
Medullary Aplasia: a severe condition associated to Thymic Epithelial Tumors
Stefano De Falco, Claudia von Arx, Carlo Buonerba, Margaret Ottaviano, Piera Federico, Filomena
Calabrese, Lucia Nappi, Pasquale Rescigno, Vincenzo Damiano, Giovannella Palmieri.
Selected as poster presentation
Abstract Presented to ASCO 2014, Chicago Illinois, USA
A case series of low-dose sorafenib plus tamoxifen in sorafenib-pretreated patients with
advanced hepatocellular carcinoma
Giovannella Palmieri, Piera Federico, Margaret Ottaviano, Carlo Buonerba, Filomena Calabrese,
Pasquale Rescigno, Anapaula De Maio, Mariateresa Micillo, Giuseppe di Lorenzo,Vincenzo
Damiano
Discussant Experiences
“Il congresso nazionale IART (IItalian Association Rare Tumours) 2016”
Nov 11 2016, Cremona, Italy
Germinal testicular cancer: therapy of the advanced stage disease
“The present and the future of soft tissue sarcoma”
March 15 2016, Naples, Italy
Trabectedin: from clinical trials to clinical practice
“La gestione ottimale dei pazienti con sarcoma dei tessuti molli”
Jun 23 2016, Vietri sul Mare, Italy
Trabectedin in soft tissue sarcoma: multitarget action, unconventional response and toxicity
“Oncology News 2015”
Oct 8 2015, Benevento, Italy
The hospital tumor board: neuroendocrine tumors teach
“GIST: percorso diagnostico terapeutico nella pratica clinica”
Feb 20 2015, Naples, Italy
Therapeutic algorithm definition for optimal patient management affected by GIST
“Clinical case contest: Convegno macroregionale SIURO”
Oct 17-18 2014, Salerno, Italy
Case report: “Germ cell cancer clinical stage I: Seminoma?”
“Le patologie tiroidee”,
March 29 2014, Mirabella Eclano, Avellino, Italy
Thyroid disfunctions and Tyrosine Kinase Inhibitors
“GIST, dalle evidenze scientifiche alla pratica clinica”,
Feb 28 2014, Naples, Italy
Clinical experience
6
“2°Mediterranean conference on rare tumors”, Dec 6-7 2013, Naples, Italy
Case report: “Relapse of germ cell cancer: Are you sure?”
Kaposi Sarcoma: our experience and a literature review
In compliance with the Italian legislative Decree no. 196 dated 30/06/2003, I hereby authorize you to use and process my personal details contained
in this document.
7
curriculum vitae
MARGARET OTTAVIANO
Dipartimento di Medicina Clinica e Chirurgia
Università di Napoli Federico II
Via S. Pansini, 5
80131, Napoli, Italia
Telefono: +39/0817462114
Fax: +39/2203147
E-mail: [email protected]
Informazioni personali
Nome e Cognome
Indirizzo
9, via Giuseppe Di Vittorio, 80046, San Giorgio a Cremano, Napoli, Italy
Telefono
081 19910297
Cellulare
3333759668
Fax
081 220 3147
E-mail
Nazionalità
Data di Nascita
Sesso
Esperienze professionali
Nome e indirizzo del datore di
lavoro
Data(da- a)
Occupazione o ruolo ricoperto
Istruzione e formazione
Data
Titolo o qualifica conseguiti
Organizzazione erogatrice
dell’istruzione e formazione
Voto
Data(da- a)
[email protected]
Italiana
03/02/1986
Femminile
Dipartimento di Medicina Clinica e Chirurgia,
Università degli studi di Napoli Federico II, Napoli, Italia
Da Agosto 2013
Medico Oncologo in formazione
2013
Laurea in Medicina e Chirurgia – Università degli Studi di Napoli, Federico II
Università degli Studi di Napoli, Federico II
110/110 cum laude e menzione alla carriera
2009-2010
Titolo o qualifica conseguiti
Exchange Erasmus Project c/o Facoltà di Medicina,
Organizzazione erogatrice
dell’istruzione e formazione
Instituto de Ciencias Biomedicas Abel Salazar,
Universidade do Porto, Oporto, Portugal
Data(da- a)
1
Margaret Ottaviano
2004
Titolo o qualifica conseguiti
Organizzazione erogatrice
dell’istruzione e formazione
Vote
Esperienza di ricerca
Data (da-a)
Titolo o qualifica conseguiti
Data (da-a)
Titolo o qualifica conseguiti
Diploma di Liceo Scientifico
Liceo Scientifico Carlo Urbani in San Giorgio a Cremano, Naples, Italy
100/100
Dal 2011
Ricerca clinica
c/o CRTR (Centro Riferimento Tumori Rari Regione Campania),
Università degli Studi di Napoli Federico II
Principalmente sui tumori epiteliali timici, tumori germinali del testicolo, sarcoma dei tessuti molli
e GIST, tumori neuroendorcini e carcinoma del distretto testa-collo, per lo sviluppo di markers
predittivi per la risposta al trattamente; partecipazione come sub-investigator a studi di fase II e
fase III
Direttore Scientifico: Prof. Giovannella Palmieri,
Direttore Scientifico CRTR, Dipartimento di Medicina Clinica e Chirurgia
Università degli studi di Napoli, Federico II
01 Maggio 2016 al 15 Giugno 2016
Spring 2016 ESMO Clnical Unit Visit Felloship winner
Borsa di studio di ricerca clinica c/o Royal Marsden Cancer Foundation, Sutton, UK
Ricerca Clinica principalmente interessata ai seguenti temi; tumori genitourinari e questioni
relative: insufficienza surrenalica in mCRPC trattati con steroidi; steroidi passati da prednisone
to dexamethasone come linea di trattamento nei mCRPC; identificazione di biomarker predittivi
di esito sfavorevole nella prognosi infausta avanzata di tumore germinale del testicolo.
Research Supervisor: Dr. Alison Reid
Consulente Oncologo Medico c/o Royal Marsden Cancer Foundation, Dipartimento di Oncologia
Urologica
Appartenenza a gruppi/
associazioni
Data(da-a)
Titolo o qualifica conseguiti
Data(da -a)
Titolo o qualifica conseguiti
Data(da-a)
Titolo o qualifica conseguiti
Data(da-a)
2
Luglio 2013
Iscrizione all’ Albo Professionale dei Medici Chirurghi di Napoli
Settembre 2013
Medico oncologo membro dell’ ENETS
Novembre 2014
Membro IGG (Italian Germinal Group)
Gennaio 2015
Titolo o qualifica conseguiti
Data(da-a)
Membro ESMO (European Society of Medical Oncology) young oncologist member
Gennaio 2017
Titolo o qualifica conseguiti
Membro ASCO ( American society of Clinical Oncology)
Competenze organizzative e
gestionali
Gestione delle emergenze oncologiche
Gestione della terapia del dolore
Gestione degli studi di fase clinica I, II, III trials e studi osservazionali
Ottima capacità di adattarssi a contesti multiculturali, maturate attraverso il mio lavoro e le mie
esperienze di studio
Spirito di squadra migliorato attraverso le mie esperienze lavorative
Alto livello di standard morali e etici;
Buone capacità di comunicazione acquisite attraverso i miei studi
Leadership
Buona esperienza di coordinamento all’interno di gruppi di lavoro
Senso dell’organizzazione
Buona esperienza in progetti di gruppo
Esperienze in studi clinici
Clinical investigator in studi di fase II sui tumori epiteliali del timo, tumori neuroendocrini, melanoma
maligno, sarcoma, carcinoma epatocellulare, istiocitosi, tumori testa-collo, e tumori germinali del
testicolo
Management di studi clinici di fase II, III e studi osservazionali
Competenze professionali
Madrelingua
Italiana
Altre Lingue
Inglese
Self-assessment
European level (*)
Altre lingue
Self-assessment
European level (*)
Altre Lingue
Self-assessment
European level (*)
Comprensione
Produzione scritta
Ascolto
Lettura
Interazione
Produzione orale
C2
C2
C1
C1
C1
Portoghese
Comprensione
Parlato
Produzione scritta
Ascolto
Lettura
Interazione
Produzione orale
C2
C2
C2
C2
C2
Spanish
Comprensione
Parlato
Produzione scritta
Ascolto
Lettura
Interazione
Produzione orale
B2
B2
B2
B2
(*) Common
3
Parlato
B2
European Framework of Reference (CEF) level
Competenze comunicative
Ho una forte capacità di analisi e di sintesi, ottime capacità comunicative e sono meticolosa e
risoluta
Competenze organizzative e
So lavorare molto bene in gruppo
gestionali
Competenze digitali
Riconoscimenti e premi
Pubblicazioni
Office
ITMIG Shanghai 2015 travel grant winner
Spring 2016 ESMO Clinical Unit Visit Fellowship winner
ITMIG San Francisco 2016 travel grant winner
ESO-ESMO 2017 Oncology masterclass
Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumor
Roberto Moretto, Chiara Alessandra Cella, Lucia Raimondo, Luigi Formisano, Lucia Nappi,
Pasquale Rescigno, Carlo Buonerba, Filomena Calabrese, Margaret Ottaviano, Giuseppe Di
Lorenzo, Elide Matano, Vincenzo Damiano, Giovannella Palmieri
Anticancer Drugs. 2013 Aug;24(7):759-64
Capecitabine plus gemcitabine in thymic epithelial tumors: final analysis of a phase II trial
Giovannella Palmieri, Carlo Buonerba, Margaret Ottaviano, Piera Federico, Filomena Calabrese,
Claudia von Arx, Ana Paula De Maio, Mirella Marino, Maurizio Lalle, Liliana Montella, Carmela
Merola, Michele Milella, Marina Bergaglio, Giuseppe Di Lorenzo, Vincenzo Damiano.
Future Oncology 2014 Nov;10(14):2141-7.
Molecular genetic alterations in EGFR CA-SSR-1 microsatellite and EGFR copy number
changes are associated with aggressiveness in Thymoma
Salvatore Conti, Enzo Gallo, Stefano Sioletic, Francesco Facciolo, Giovannella Palmieri, Libero
Lauriola, Amelia Evoli, Robert Martucci, Anna Di Benedetto, Flavia Novelli, Diana Giannarelli, Gloria
Deriu, Pierluigi Granone, Margaret Ottaviano, Paola Muti, Edoardo Pescarmona, Mirella Marino
J Thorac Dis. 2016 Mar;8(3):386-95.
The future of melanoma therapy: developing new drugs and improving the use of old ones.
Palumbo G, Di Lorenzo G, Ottaviano M, Damiano V.
Future Oncol. 2016 Oct 7. [Epub ahead of print]
Abstracts
Abstract Presented to ITMIG 2016, San Francisco, LA, USA
Proposed paradigm for the second line treatment in thymic epithelial tumours
Margaret Ottaviano, Vincenzo Damiano, Silvana Del Vecchio, Sabrina Segreto, Pasquale
Rescigno, Elide Matano, Mirella Marino, Giovannella Palmieri.
Selected as poster presentation
The evolving role of Sunitinib in the management of highly pre-treated thymic carcinoma
Giovannella Palmieri, Margaret Ottaviano, Pasquale Rescigno, Mirella Marino, Giuliano Palumbo,
Alfredo Di Giovanni, Carmen Forino, Vincenzo Damiano.
Selected as poster presentation
The unexplored paradox of autoimmunity and immunodeficiency in thymomas: a
monocentric experience
Margaret Ottaviano, Vincenzo Damiano, Alfredo Di Giovanni, Carmen Forino, Giovannella Palmieri.
Selected as poster presentation
4
Platinum based chemotherapy in advanced thymic epithelail tumours: always the best
choice?
Vincenzo Damiano, Margaret Ottaviano, Elide Matano, Alfredo Di Giovanni, Sabino De Placido,
Giovannella Palmieri.
Selected as poster presentation
Abstract Presented to ITMIG 2015, Shanghai, China, Asia
18 FDG-PET/CT for early prediction of response to first line platinum chemotherapy in
advanced TETs
Giovannella Palmieri, Margaret Ottaviano, Silvana Del Vecchio, Sabrina Segreto, Irene Tucci,
Vincenzo Damiano
Selected as poster presentation
Effectiveness of cytotoxic agent etoposide after target therapy in advanced thymic tumors
Margaret Ottaviano, Vincenzo Damiano, Claudia von Arx, Irene Tucci, Lucia Nappi, Pasquale
Rescigno, Giuliano Palumbo, Sabino de Placido, Giovannella Palmieri.
Selected as poster presentation
Is the Octreoscan score a predictive factor of response to Somatostatin analogs treatment?
Vincenzo Damiano, Margaret Ottaviano, Silvana Del Vecchio, Sabrina Segreto, Irene Tucci,
Claudia von Arx, Giuliano Palumbo, Sara Pellegrino, Sabino de Placido, Mirella Marino, Giovannella
Palmieri.
Selected as poster presentation
Diagnosis of advanced thymic epithelial tumor in patients previously affected by thymic
hyperplasia
Vincenzo Damiano, Margaret Ottaviano, Irene Tucci, Elide Matano, Sabino de Placido, Giovannella
Palmieri
Selected as poster presentation
Abstract Presented to ASCO 2015, Chicago Illinois, USA
Somatostatin analogs as maintenance therapy in heavily pretreated thymic epithelial tumor
Giovannella Palmieri, Margaret Ottaviano, Lucia Nappi, Pasquale Rescigno, Mirella Marino, Liliana
Montella, Mariateresa Micillo, Giuliano Palumbo, Silvana Del Vecchio, Vincenzo Damiano
Selected as poster presentation
Effectiveness of somatostatin analogs plus prednisone in aggressive histotype and
advanced stage of thymic epithelial tumors
Margaret Ottaviano, Vincenzo Damiano, Lucia Nappi, Pasquale Rescigno, Liliana Montella, Mirella
Marino, Silvana Del Vecchio, Irene Tucci, Claudia von Arx, Giovannella Palmieri
Selected as poster presentation
Abstract presented to AIOM 2015, Rome, Italy, Europe
Correlation between plasmatic levels of vitamin D and testicular cancer
Lucia Nappi, Vincenzo Damiano, Margaret Ottaviano, Pasquale Rescigno, Caterina Condello,
Claudio Curcio, Ciro Candido, Elide Matano, Giovannella Palmieri
Selected as poster presentation
Abstract Presented to ITMIG 2014, Antwerp, Belgium, Europe
Effectiveness of dual target Everolimus and Somatostatin Analogs in heavily
Pretreated Thymic Epithelial Tumors.
5
Giovannella Palmieri, Margaret Ottaviano, Carlo Buonerba, Piera Federico, Filomena Calabrese,
Claudia von Arx, Stefano De Falco, Lucia Nappi, Pasquale Rescigno, Mirella Marino, Vincenzo
Damiano.
Selected as poster presentation
Long lasting management of functional neuroendocrine thymic carcinoma
Margaret Ottaviano, Claudia von Arx, Stefano De Falco, Carlo Buonerba, Piera Federico, Filomena
Calabrese, Lucia Nappi, Pasquale Rescigno, Vincenzo Damiano, Giovannella Palmieri.
Selected as poster presentation
Medullary Aplasia: a severe condition associated to Thymic Epithelial Tumors
Stefano De Falco, Claudia von Arx, Carlo Buonerba, Margaret Ottaviano, Piera Federico, Filomena
Calabrese, Lucia Nappi, Pasquale Rescigno, Vincenzo Damiano, Giovannella Palmieri.
Selected as poster presentation
Abstract Presented to ASCO 2014, Chicago Illinois, USA
A case series of low-dose sorafenib plus tamoxifen in sorafenib-pretreated patients with
advanced hepatocellular carcinoma
Giovannella Palmieri, Piera Federico, Margaret Ottaviano, Carlo Buonerba, Filomena Calabrese,
Pasquale Rescigno, Anapaula De Maio, Mariateresa Micillo, Giuseppe di Lorenzo,Vincenzo
Damiano
Conferenze
(Partecipazione come Discussant)
“Il congresso nazionale IART (IItalian Association Rare Tumours) 2016”
Nov 11 2016, Cremona, Italia
Il tumore germinale del testicolo: la terapia avanzata
”Il presente e il futuro del sarcoma dei tessuti molli”
Marzo 15 2016, Napoli, Italia
Trabectedina: dagli studi clinici alla pratica clinica
“La gestione ottimale dei pazienti con sarcoma dei tessuti molli”
Giugno 23 2016, Vietri sul Mare, Italia
Trabectedina nei sarcoma dei tessuti molli: azione multitarget, risposta non convenzionale e
tossicità
“Oncology News 2015”
Ottobre 8 2015, Benevento, Italia
Il tumor board: I tumori neuroendocrini insegnano
“GIST: percorso diagnostico terapeutico nella pratica clinica”
Febbraio 20 2015, Napoli, Italia
Definizione di algoritmo terapeutico per il management ottimale del paziente affetto da GIST
“Clinical case contest: Convegno macroregionale SIURO”
Ottobre 17-18 2014, Salerno, Italia
Case report: “ I tumori germinali del testicolo stage I: Seminoma?”
“Le patologie tiroidee”,
Marzo 29 2014, Mirabella Eclano, Avellino, Italia
Disfunzioni tiroidee e gli inibitori della tirosin- kinasi
“GIST, dalle evidenze scientifiche alla pratica clinica”,
Febbraio 28 2014, Napoli, Italia
Esperienza Clinica
“2°Conferenza del Mediterraneo sui tumori rari”
Dicembre 6-7 2013, Napoli, Italia
6
Case report: “Ricaduta del tumore germinale del testicolo: Siamo sicuri?”
Kaposi Sarcoma: our experience and a literature review
Autorizzo il trattamento dei miei dati personali ai sensi del Decreto Legislativo 30 giugno 2003, n. 196 "Codice in materia di protezione dei dati
personali”.
7
